2021 publications. Published 3.3.2021.
News
Ben Hinz, a Biomedical Engineering undergraduate researcher in the laboratory of Lori Wallrath, was awarded a Victoria Finnerty Award to present a poster titled "Modeling muscular dystrophy in Drosophila: A study of lamins and interaction partners" at the 62nd Annual Drosophila Research Conference ( https://genetics-gsa.org/awards/victoria-finnerty-undergraduate-travel-awards /).
Undergraduate Biochemistry alumnus, Dr. Susan R. Wente, selected as 14th President of Wake Forest University.
Recent research findings from Lori Wallrath's laboratory were presented at the ASCB/EMBO Cell Bio Virtual 2020 Conference.
Dr. Pamela Geyer quoted in The New York Times.
Dr. Debbie Thurmond at the frontline of Unites States first clinical trial for a type 1 diabetes vaccine.
Congratulations to Drs. Ryan Mahling and William Hacker for successfully defending their theses this fall.
Please join Dr. Marc Wold, Director of Undergraduate Studies and Honors Advisor, in congratulating the Fall 2020 Biochemistry Honors graduates and their research mentors for a job well done. JADE MILLER - Inhibition of RAD52 in BRCA2-Deficient Cancer Cells Mentor: Maria Spies JACOB LAM - Activating Transcription Factor 4 Controls Mitochondrial Morphology and Metabolism in Skeletal Muscle Mentor: E. Dale Abel; Antentor Hinton, Jr.
Drs. Lori Wallrath, Professor of Biochemistry, and Arlene Drack, Professor of Ophthalmology and Visual Sciences, received a generous philanthropic donation to establish the Wallrath Research Fund. This gift will support the joint research project between Dr. Wallrath and Drack which is focused on the generation and characterization of fruit flies that possess a mutation of a form of retinitis pigmentosa, a rare genetic blinding eye disease. The goal of this project is to allow researchers to better understand the disease and open new avenues for therapies. Part of the gift will support a graduate student focused on basic science research under the tutelage of Drs. Wallrath and Drack. The donor family has a strong interest in furthering vision research and hopes that their philanthropic support can help lead to new treatments for these types of rare genetic eye conditions in the future...
Dr. Ashley Spies, Associate Professor of Biochemistry and Pharmaceutical Science Experimental Therapeutics, has been awarded an NIH R01 grant for his project entitled, "Dialing down caspase-7 through allosteric control: An integrated approach." Congratulations Dr. Ashley Spies!